$103 Million is the total value of Ally Bridge Group (NY) LLC's 30 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 53.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $8,583,142 | -4.5% | 185,261 | -14.7% | 8.35% | +40.7% |
| Buy | AADI BIOSCIENCE INC | $8,121,352 | +361.2% | 632,997 | +407.9% | 7.90% | +579.4% | |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $7,557,877 | – | 474,741 | +100.0% | 7.35% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $6,980,848 | +10.9% | 1,191,271 | +27.9% | 6.79% | +63.4% |
| GLPG | Buy | GALAPAGOS NVspon adr | $6,215,597 | +90.6% | 140,054 | +83.1% | 6.05% | +180.9% |
| ALLK | Buy | ALLAKOS INC | $5,240,305 | +43.1% | 622,364 | +4.0% | 5.10% | +110.9% |
| SGEN | Sell | SEAGEN INC | $4,836,988 | -61.8% | 37,639 | -59.3% | 4.71% | -43.7% |
| AVIR | Buy | ATEA PHARMACEUTICALS INC | $4,630,558 | +126.1% | 962,694 | +167.4% | 4.50% | +233.2% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $4,538,965 | +5.2% | 119,008 | +8.0% | 4.42% | +54.9% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $4,514,339 | -34.9% | 3,730,859 | -41.3% | 4.39% | -4.0% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $4,044,443 | -47.4% | 326,428 | -56.0% | 3.94% | -22.5% |
| SANA | Buy | SANA BIOTECHNOLOGY INC | $4,010,328 | -9.1% | 1,015,273 | +38.1% | 3.90% | +33.9% |
| ALKS | Sell | ALKERMES PLC | $3,710,512 | -44.6% | 142,002 | -52.7% | 3.61% | -18.4% |
| SYROS PHARMACEUTICALS INC | $3,117,567 | -44.3% | 868,403 | 0.0% | 3.03% | -17.9% | ||
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $3,048,501 | -63.5% | 896,618 | -41.3% | 2.97% | -46.2% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $3,016,334 | +117.8% | 1,334,661 | +208.3% | 2.93% | +221.0% |
| SELB | Buy | SELECTA BIOSCIENCES INC | $2,891,076 | +427.6% | 2,558,474 | +665.4% | 2.81% | +677.1% |
| New | BIOHAVEN LTD | $2,485,700 | – | 179,085 | +100.0% | 2.42% | – | |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $2,449,694 | -68.0% | 125,176 | -73.9% | 2.38% | -52.8% |
| MRTX | New | MIRATI THERAPEUTICS INC | $2,153,131 | – | 47,520 | +100.0% | 2.10% | – |
| RGEN | Sell | REPLIGEN CORP | $2,062,196 | -34.1% | 12,180 | -27.2% | 2.01% | -2.9% |
| EPIX | New | ESSA PHARMA INC | $2,045,119 | – | 811,555 | +100.0% | 1.99% | – |
| MDVL | MEDAVAIL HOLDINGS INC | $1,767,290 | -61.4% | 5,894,897 | 0.0% | 1.72% | -43.1% | |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $1,500,790 | – | 630,584 | +100.0% | 1.46% | – |
| MOR | Buy | MORPHOSYS AGsponsored ads | $1,452,055 | +203.8% | 405,602 | +326.8% | 1.41% | +347.2% |
| RAPID MICRO BIOSYSTEMS INC | $790,620 | -65.0% | 699,664 | 0.0% | 0.77% | -48.5% | ||
| CRIS | Buy | CURIS INC | $455,068 | +146.0% | 827,397 | +213.4% | 0.44% | +263.1% |
| NAUT | Sell | NAUTILUS BIOTECHNOLOGY INC | $286,618 | -83.6% | 159,232 | -80.7% | 0.28% | -75.8% |
| Sell | SCIENCE 37 HOLDINGS INC | $159,602 | -92.2% | 384,397 | -69.6% | 0.16% | -88.5% | |
| DNLI | New | DENALI THERAPEUTICS INC | $124,561 | – | 4,479 | +100.0% | 0.12% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -86,242 | -100.0% | -0.07% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -64,295 | -100.0% | -0.10% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -533,501 | -100.0% | -0.42% | – |
| EDIT | Exit | EDITAS MEDICINE INC | $0 | – | -82,900 | -100.0% | -0.67% | – |
| VOR | Exit | VOR BIOPHARMA INC | $0 | – | -255,162 | -100.0% | -0.67% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -100,000 | -100.0% | -0.92% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -25,000 | -100.0% | -1.10% | – |
| Exit | ISOPLEXIS CORP | $0 | – | -1,522,364 | -100.0% | -1.73% | – | |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -204,014 | -100.0% | -2.01% | – |
| ACET | Exit | ADICET BIO INC | $0 | – | -244,400 | -100.0% | -2.29% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -12,240 | -100.0% | -2.85% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -377,000 | -100.0% | -2.98% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -74,262 | -100.0% | -3.03% | – |
| Exit | GSK PLCsponsored adr | $0 | – | -255,000 | -100.0% | -4.96% | – | |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -230,000 | -100.0% | -5.77% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Fan Yu #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDAVAIL HOLDINGS INC | 11 | Q2 2023 | 8.9% |
| UNUM THERAPEUTICS INC | 8 | Q3 2022 | 7.3% |
| RAPID MICRO BIOSYSTEMS INC-A | 8 | Q2 2023 | 3.5% |
| FATE THERAPEUTICS INC | 7 | Q2 2022 | 5.8% |
| VIRIDIAN THERAPEUTICS INC | 7 | Q2 2023 | 6.8% |
| SYROS PHARMACEUTICALS INC | 7 | Q2 2022 | 4.9% |
| REPLIGEN CORP | 7 | Q4 2022 | 6.5% |
| NAUTILUS BIOTECHNOLOGY INC | 7 | Q4 2022 | 3.8% |
| ARVINAS INC | 6 | Q1 2022 | 7.5% |
| NUVATION BIO INC | 6 | Q2 2022 | 4.9% |
View Ally Bridge Group (NY) LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | November 19, 2020 | 1,420,500 | 8.0% |
View Ally Bridge Group (NY) LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-06-21 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-03-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Ally Bridge Group (NY) LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.